RxDoctor Payments Data

Justin Budnik, MD

Radiation Oncology · Watertown, NYNPI 1609263078

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,538 of the $3,951 with a category attached, or 64.2%. 35 manufacturers reported payments, led by Boston Scientific at 56.1% of the total. 2025 is the largest year on record at $2,882, more than ten times the $29 reported in 2020.

$3,951in general payments, 2019–2025

Across 67 payments — averaging $58.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Bayer$532
  • Daiichi Sankyo Inc.$130
  • Novocure Inc.$99
  • Teleflex LLC$72
  • AstraZeneca$66
  • plus $835 from 29 others

What the payments were for

  • Consulting fees$251%
  • Speaking & faculty fees$47612%
  • Travel & lodging$86422%
  • Food & beverage$2,53864%
  • Education$481%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,951 in reported general payments places this provider in the 80th percentile of 397 radiation oncology providers in New York.

See all radiation oncology providers in New York →

Medicare billing

Part B allowed, 2024
$278,407
Medicare patients
317
Services billed
3,131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abiraterone Acetate27$164,573
Oxycodone Hcl107$9,427
Lidocaine Hcl ViscousLidocaine Hcl76$888
Tamsulosin Hcl83$730
Memantine Hcl16$584
Albuterol Sulfate HfaAlbuterol Sulfate13$524
Morphine Sulfate24$503
Tranexamic Acid13$382
Ondansetron Hcl42$347
Ondansetron OdtOndansetron15$313
Dexamethasone38$309
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$247
Gabapentin29$235
Levothyroxine Sodium32$223
Venlafaxine Hcl ErVenlafaxine Hcl23$197

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Watertown

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →